NeueHealth, Inc. (NEUE) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist NeueHealth, Inc. (NEUE) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026NeueHealth, Inc. (NEUE) Gesundheitswesen & Pipeline-Uebersicht
NeueHealth, Inc. delivers healthcare services through its NeueCare and NeueSolutions segments, focusing on the ACA marketplace, Medicare, and Medicaid. Operating risk-bearing clinics and enabling providers in performance-based arrangements, NeueHealth aims to improve healthcare access and outcomes in a competitive landscape.
Investmentthese
NeueHealth, Inc. presents a complex investment case. The company's focus on the ACA marketplace, Medicare, and Medicaid offers exposure to growing segments of the healthcare market. The NeueCare segment's integrated care model, with embedded services like pharmacy and lab, could drive efficiencies and improve patient outcomes. However, the company's negative P/E ratio of -0.62 and a negative profit margin of -10.7% indicate current challenges in achieving profitability. The company's market capitalization is $0.06 billion as of March 2026. Key catalysts include successful expansion of the NeueCare clinic network and increased adoption of the NeueSolutions platform by providers. Risks include regulatory changes in the healthcare industry and the company's ability to manage medical costs effectively.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.06 billion indicates a small-cap company with potential for growth but also higher volatility.
- P/E ratio of -0.62 reflects current unprofitability, requiring scrutiny of turnaround strategies.
- Gross margin of 24.2% suggests potential for improvement through cost management and operational efficiencies.
- Beta of 0.60 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- The company rebranded from Bright Health Group, Inc. to NeueHealth, Inc. in January 2024, signaling a strategic shift.
Wettbewerber & Vergleichsunternehmen
Staerken
- Integrated care model with embedded services.
- Proprietary technology platform for value-based care.
- Established clinic network.
- Focus on growing segments of the healthcare market (ACA, Medicare, Medicaid).
Schwaechen
- Negative P/E ratio and profit margin.
- Small market capitalization.
- Limited brand recognition.
- High level of competition in the healthcare industry.
Katalysatoren
- Upcoming: Expansion of the NeueCare clinic network into new geographic markets by Q4 2026.
- Ongoing: Increased adoption of the NeueSolutions platform by providers and medical groups.
- Ongoing: Strategic partnerships with other healthcare organizations to expand service offerings.
- Upcoming: Positive regulatory changes in the healthcare industry that support value-based care initiatives.
Risiken
- Potential: Regulatory changes in the healthcare industry that could negatively impact NeueHealth's business model.
- Ongoing: Increasing competition from established players and new entrants in the healthcare market.
- Ongoing: Rising medical costs that could erode profit margins.
- Potential: Economic downturn that could reduce demand for healthcare services.
Wachstumschancen
- Expansion of NeueCare Clinic Network: NeueHealth can expand its network of owned and affiliated clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands. This expansion would allow the company to reach more patients and increase its market share in key geographic areas. The market for primary care services is estimated at $260 billion annually, providing a significant opportunity for growth. Timeline: Ongoing.
- Adoption of NeueSolutions Platform: The NeueSolutions segment can drive growth by increasing adoption of its platform among providers and medical groups. This platform enables providers to succeed in performance-based arrangements, which are becoming increasingly prevalent in the healthcare industry. The market for value-based care solutions is projected to reach $1 trillion by 2028. Timeline: Ongoing.
- Strategic Partnerships: NeueHealth can form strategic partnerships with other healthcare providers, payors, and technology companies to expand its reach and enhance its service offerings. These partnerships could provide access to new markets, technologies, and expertise. The market for healthcare partnerships is growing rapidly, with a focus on collaboration and innovation. Timeline: Ongoing.
- Technology Integration: Investing in technology to improve care coordination, patient engagement, and data analytics can drive growth and improve efficiency. This includes implementing telehealth solutions, developing mobile apps for patients, and using data analytics to identify and manage high-risk patients. The market for healthcare technology is projected to reach $390 billion by 2024. Timeline: Ongoing.
- Medicare Advantage Expansion: NeueHealth can expand its presence in the Medicare Advantage market, which is experiencing significant growth due to the aging population and increasing popularity of managed care plans. This expansion would allow the company to tap into a large and growing market segment. The Medicare Advantage market is projected to reach $590 billion by 2027. Timeline: Ongoing.
Chancen
- Expansion of clinic network.
- Increased adoption of NeueSolutions platform.
- Strategic partnerships.
- Medicare Advantage expansion.
Risiken
- Regulatory changes in the healthcare industry.
- Increasing competition.
- Rising medical costs.
- Economic downturn.
Wettbewerbsvorteile
- Integrated Care Model: NeueHealth's integrated care model, with embedded services like pharmacy and lab, provides a competitive advantage by improving care coordination and patient convenience.
- Proprietary Technology Platform: The NeueSolutions platform provides a competitive advantage by enabling providers to succeed in performance-based arrangements.
- Established Clinic Network: The company's network of owned and affiliated clinics provides a strong foundation for growth and expansion.
Ueber NEUE
NeueHealth, Inc., established in 2015 and headquartered in Doral, Florida, is a healthcare company focused on providing a range of services to health consumers, providers, and payors in the United States. Formerly known as Bright Health Group, Inc., the company rebranded to NeueHealth, Inc. in January 2024, signaling a strategic shift in its business approach. NeueHealth operates through two primary segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to individuals covered by the ACA marketplace, Medicare, and Medicaid through a network of owned and affiliated clinics. These clinics operate under the brand names Centrum Health, AssociatesMD, and Premier Medical Associates. The segment offers an integrated system care solution, including embedded pharmacy, laboratory, radiology, and population health focused specialty services. It also provides chronic care management, transitions of care, and referral management services. The NeueSolutions segment focuses on enabling providers and medical groups to succeed in performance-based arrangements. This segment also participates in programs designed to improve healthcare access for Medicare beneficiaries. NeueHealth's business model is centered around providing comprehensive and coordinated care, leveraging technology and data analytics to improve patient outcomes and reduce costs. The company aims to create a more efficient and effective healthcare system by aligning incentives and empowering providers to deliver high-quality care.
Was das Unternehmen tut
- Provides healthcare services to health consumers, providers, and payors in the United States.
- Operates through NeueCare and NeueSolutions segments.
- Delivers healthcare services to ACA marketplace, Medicare, and Medicaid enrollees.
- Operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands.
- Offers integrated system care solutions, including pharmacy, laboratory, and radiology services.
- Provides chronic care management, transitions of care, and referral management services.
- Enables providers and medical groups to succeed in performance-based arrangements.
- Participates in programs designed to improve healthcare access for Medicare beneficiaries.
Geschaeftsmodell
- Generates revenue through providing healthcare services to patients in its owned and affiliated clinics.
- Earns fees from providers and medical groups for using the NeueSolutions platform.
- Participates in risk-sharing arrangements with payors, where it shares in the cost savings generated by its care management programs.
Branchenkontext
NeueHealth operates in the dynamic and highly regulated healthcare industry. The industry is characterized by increasing demand for value-based care, driven by rising healthcare costs and a growing emphasis on patient outcomes. The competitive landscape includes established players such as ACHL, AKYA, CCLD, HTBX, and NAKA, as well as new entrants focused on innovative care delivery models. NeueHealth's focus on integrated care and performance-based arrangements aligns with industry trends, but the company faces challenges in scaling its operations and achieving profitability in a competitive market.
Wichtige Kunden
- Health consumers enrolled in ACA marketplace, Medicare, and Medicaid plans.
- Providers and medical groups seeking to improve their performance in value-based care arrangements.
- Payors looking to partner with organizations that can help them manage costs and improve patient outcomes.
Finanzdaten
Chart & Info
NeueHealth, Inc. (NEUE) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Earnings Scheduled For August 7, 2025
benzinga · 7. Aug. 2025
-
Earnings Scheduled For March 20, 2025
benzinga · 20. März 2025
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer NEUE.
Kursziele
Wall-Street-Kurszielanalyse fuer NEUE.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von NEUE auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Fuehrung: George Lawrence Mikan III
Chief Executive Officer
George Lawrence Mikan III serves as the Chief Executive Officer of NeueHealth, Inc. His background includes extensive experience in the healthcare industry, with a focus on managed care and healthcare delivery. Prior to joining NeueHealth, Mikan held leadership positions at various healthcare organizations, where he was responsible for strategic planning, operations, and financial management. He has a proven track record of driving growth and improving operational efficiency. Mikan's expertise in value-based care and population health management is critical to NeueHealth's success.
Erfolgsbilanz: Since assuming the role of CEO, George Lawrence Mikan III has overseen the rebranding of the company from Bright Health Group, Inc. to NeueHealth, Inc., signaling a strategic shift in the company's focus. He is focused on improving the company's financial performance and expanding its market presence. Mikan is also leading efforts to enhance the company's technology platform and improve care coordination.
NeueHealth, Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for NEUE?
NeueHealth, Inc. (NEUE) currently holds an AI score of 42/100, indicating low score. Key strength: Integrated care model with embedded services.. Primary risk to monitor: Potential: Regulatory changes in the healthcare industry that could negatively impact NeueHealth's business model.. This is not financial advice.
How frequently does NEUE data refresh on this page?
NEUE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NEUE's recent stock price performance?
Recent price movement in NeueHealth, Inc. (NEUE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated care model with embedded services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NEUE overvalued or undervalued right now?
Determining whether NeueHealth, Inc. (NEUE) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NEUE?
Before investing in NeueHealth, Inc. (NEUE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NEUE to a portfolio?
Potential reasons to consider NeueHealth, Inc. (NEUE) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Integrated care model with embedded services.. Additionally: Proprietary technology platform for value-based care.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of NEUE?
Yes, most major brokerages offer fractional shares of NeueHealth, Inc. (NEUE) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NEUE's earnings and financial reports?
NeueHealth, Inc. (NEUE) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for NEUE earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data may be outdated.
- AI analysis pending.